Bio
Joined SVLS in 1991. Has been responsible for past investments in Alantos, Auxilium, ESBATech, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed and current investments including Bicycle, EUSA and RespiVert. Prior to joining SVLS, worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. First class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA.
Education
|
Harvard Business SchoolMBA in Business Administration
|
|
|
University of OxfordN/A
|